$ Value
$0
Shares
6,200
Price
$0
Filed
May 9
Insider
Name
Bruls Annette
Title
CVP, EMEACLA
CIK
0002032351
Roles
Transaction Details
Transaction Date
2025-05-08
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
14,280
Footnotes
These restricted stock units were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. | These options were granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. | Reflects the target number of shares (the Target Award) covered by restricted stock unites granted on May 8, 2025 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 8, 2028. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards.
Filing Info
Bruls Annette's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-07-11 | EW | F | $9K |
| 2025-05-08 | EW | A | $0 |
| 2025-05-08 | EW | A | $0 |
| 2025-05-08 | EW | A | $0 |
Other Insiders at EW (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
BOBO DONALD E JR
CVP,Strategy/Corp Development
|
— | $4.8M | 2026-04-02 |
|
Ullem Scott B.
CVP, Chief Financial Officer
|
— | $2.1M | 2026-04-09 |
|
Zovighian Bernard J
CEO
|
— | $1.7M | 2026-02-13 |
|
Lippis Daniel J.
CVP, TAVR
|
— | $170K | 2026-04-06 |
|
Dahl Andrew M.
SVP, Corporate Controller
|
— | — | 2026-02-22 |